logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Strategic Partners
      • Lorraine Boyle
      • Dominika Dabrowski
      • Stephen Filbey
      • Brent Korte
    • Careers
  • SERVICES
    • Our Services
    • Strategic Advice
      • MORSE pCPA Assessment
      • MORSE HTA Strategic Advice
    • Analyses
    • Advisory Boards
      • MORSE Advisory Panel (MAP)
    • Training
      • RWE/Innovative Agreements
      • Private Payer
      • Negotiation Simulation
      • Reimbursement Training
    • Reports
      • Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
      • Drugs for Rare Diseases Sub-Report
      • Oncology and Biosimilar Sub-Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US
logo-top-c-r
logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Strategic Partners
      • Lorraine Boyle
      • Dominika Dabrowski
      • Stephen Filbey
      • Brent Korte
    • Careers
  • SERVICES
    • Our Services
    • Strategic Advice
      • MORSE pCPA Assessment
      • MORSE HTA Strategic Advice
    • Analyses
    • Advisory Boards
      • MORSE Advisory Panel (MAP)
    • Training
      • RWE/Innovative Agreements
      • Private Payer
      • Negotiation Simulation
      • Reimbursement Training
    • Reports
      • Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
      • Drugs for Rare Diseases Sub-Report
      • Oncology and Biosimilar Sub-Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US

MORSE Consulting Releases its Fourth Annual pCPA Year in Review Infographic (2020 Edition)

February 10, 2021
-
Market Access News, Publications
-
Posted by MORSE - < 1 min read.

MORSE Consulting is pleased to release our Fourth Annual pCPA Year in Review Infographic – 2020 Edition.  This resource is aimed at helping market access stakeholders understand the top-line pCPA highlights from 2020.

This infographic compares year-over-year metrics including:

  • pCPA activity summary;
  • the effect of COVID-19 on under-consideration files;
  • average time to complete a negotiation; and
  • files adjudicated by the pCPA by type in 2020.

This infographic is an excerpt from MORSE Consulting’s 2021 Canadian Reimbursement and Forecasting Timelines (CRaFT) Report, which will be released in May 2021.

Click on graphic to print or see full-size OR download PDF.

 

Please contact info@morseconsulting.ca regarding any questions on this infographic or on the CRaFT report.

Embed this infographic (cut and paste code) on your website with attribution:

 

 

To receive updates similar to this one please be sure to sign up for MORSE Signals, our free e-mail newsletter service.

Share
Tags
Biosimilars
CADTH
COVID-19
Market Access
Oncology
Pan Canadian Pharmaceutical Alliance
Pandemic
pCPA
pCPAO
Reimbursement
← PREVIOUS POST
January 2021 Brings a Substantial Jump in the Number of Files Initiated by the pCPA
NEXT POST →
Action Being Taken to Reduce the Growing Number of Files Under Consideration

Contact Us
MORSE Consulting Inc.
Toronto | Ottawa, Canada
+1-647-717-3179 (Toronto)
+1-613-864-8645 (Ottawa)
info@morseconsulting.ca
Social
Connect & Follow:

New Report

Newsletter – MORSE Signals
Sign up for our free e-mail newsletter service and receive timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

Sign Up
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2023 MORSE Consulting Inc. All rights reserved. | Site by Directica Media
MORSE Consulting Releases its Fourth Annual pCPA Year in Review Infographic (2020 Edition)